Cargando…
SAT-117 Refractory Paraneoplastic Non Islet Cell Tumor Hypoglycemia (NICTH) from Hepatocellular Carcinoma Managed with Somatostatin Analogue and Glucocorticoids
Non islet cell tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome generally seen in tumors of mesenchymal and hepatic origin. This syndrome is characterized by life threatening hypoglycemia caused by over expression of high molecular weight insulin-like growth factor 2 (IGF 2). The main st...
Autores principales: | Siddiqui, Mahwash Fatima, Vora, Amy, Ali, Sadia, Mirfakhraee, Sasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208592/ http://dx.doi.org/10.1210/jendso/bvaa046.986 |
Ejemplares similares
-
Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia
por: Siddiqui, Mahwash, et al.
Publicado: (2020) -
THU560 Serum miRNA-483 As A Diagnostic And Therapeutic Marker Of IGF-II-producing Non-islet Cell Tumor Hypoglycemia (NICTH)
por: Okazaki-Hada, Mikiko, et al.
Publicado: (2023) -
SAT-LB24 Association of Expression of Somatostatin Receptor 2 Subtype in Non-Pituitary Neuroendocrine Tumors With Response to Treatment With Somatostatin Analogues
por: Siddiqui, Abdullah, et al.
Publicado: (2020) -
SAT-127 Localization and Treatment of the Ectopic ACTH Syndrome Using Somatostatin Analogues
por: Mago, Sheena, et al.
Publicado: (2020) -
A Case of Non-Islet Cell Tumor Hypoglycemia (NICTH) Associated with Gastrointestinal Stromal Tumor (GIST)
por: Wilson, John M., et al.
Publicado: (2017)